AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Vitamin D and cancer: Effects of 1,25(OH)(2)D-3 and its analogs on growth control and tumorigenesis
Authors: Hansen, CM Binderup, L Hamberg, KJ Carlberg, C
Citation: Cm. Hansen et al., Vitamin D and cancer: Effects of 1,25(OH)(2)D-3 and its analogs on growth control and tumorigenesis, FRONT BIOSC, 6, 2001, pp. D820-D848
Examination of structurally selective derivatization of vitamin D-3 analogues by electrospray mass spectrometry
Authors: Weiskopf, AS Vouros, P Cunniff, J Binderup, E Bjorkling, F Binderup, L White, MC Posner, GH
Citation: As. Weiskopf et al., Examination of structurally selective derivatization of vitamin D-3 analogues by electrospray mass spectrometry, J MASS SPEC, 36(1), 2001, pp. 71-78
Vitamin D compounds exert anti-apoptotic effects in human osteosarcoma cells in vitro
Authors: Hansen, CM Hansen, D Holm, PK Binderup, L
Citation: Cm. Hansen et al., Vitamin D compounds exert anti-apoptotic effects in human osteosarcoma cells in vitro, J STEROID B, 77(1), 2001, pp. 1-11
Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells
Authors: Martinsson, P Liminga, G Dhar, S de la Torre, M Lukinius, A Jonsson, E Hassan, SB Binderup, L Kristensen, J Larsson, R
Citation: P. Martinsson et al., Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells, EUR J CANC, 37(2), 2001, pp. 260-267
Inhibitory effects of 1 alpha,25-dihydroxyvitamin D-3 on the G(1)-S phase-controlling machinery
Authors: Jensen, SS Madsen, MW Lukas, J Binderup, L Bartek, J
Citation: Ss. Jensen et al., Inhibitory effects of 1 alpha,25-dihydroxyvitamin D-3 on the G(1)-S phase-controlling machinery, MOL ENDOCR, 15(8), 2001, pp. 1370-1380
MCF-7/VDR: A new vitamin D resistant cell line
Authors: Hansen, CM Rohde, L Madsen, MW Hansen, D Colston, KW Pirianov, G Holm, PK Binderup, L
Citation: Cm. Hansen et al., MCF-7/VDR: A new vitamin D resistant cell line, J CELL BIOC, 82(3), 2001, pp. 422-436
In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients
Authors: Jonsson, E Friberg, LE Karlsson, MO Hassan, SB Nygren, P Kristensen, J Tholander, B Binderup, L Larsson, R
Citation: E. Jonsson et al., In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients, CANCER LETT, 162(2), 2001, pp. 193-200
Synthetic low-calcaemic vitamin D-3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells
Authors: Oh, YS Kim, EJ Schaffer, BS Kang, YH Binderup, L MacDonald, RG Park, JHY
Citation: Ys. Oh et al., Synthetic low-calcaemic vitamin D-3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells, MOL C ENDOC, 183(1-2), 2001, pp. 141-149
Molecular evaluation of vitamin D-3 receptor agonists designed for topicaltreatment of skin diseases
Authors: Bury, Y Ruf, D Hansen, CM Kissmeyer, AM Binderup, L Carlberg, C
Citation: Y. Bury et al., Molecular evaluation of vitamin D-3 receptor agonists designed for topicaltreatment of skin diseases, J INVES DER, 116(5), 2001, pp. 785-792
Cellular pharmacodynamics of the cytotoxic guanidino-containing drug CHS 828. Comparison with methylglyoxal-bis(guanplhydrazone)
Authors: Ekelund, S Sjoholm, A Nygren, P Binderup, L Larsson, R
Citation: S. Ekelund et al., Cellular pharmacodynamics of the cytotoxic guanidino-containing drug CHS 828. Comparison with methylglyoxal-bis(guanplhydrazone), EUR J PHARM, 418(1-2), 2001, pp. 39-45
Cell death with atypical features induced by the novel antitumoral drug CHS 828, in human U-937 GTB cells
Authors: Martinsson, P de la Torre, M Binderup, L Nygren, P Larsson, R
Citation: P. Martinsson et al., Cell death with atypical features induced by the novel antitumoral drug CHS 828, in human U-937 GTB cells, EUR J PHARM, 417(3), 2001, pp. 181-187
Seocalcitol (EB 1089): A vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation
Authors: Hansen, CM Hamberg, KJ Binderup, E Binderup, L
Citation: Cm. Hansen et al., Seocalcitol (EB 1089): A vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation, CUR PHARM D, 6(7), 2000, pp. 803-828
Effect of a novel vitamin D-3 analog, EB1089, on G(1) cell cycle regulatory proteins in HL-60 cells
Authors: Seol, JG Park, WH Kim, ES Jung, CW Binderup, L Koeffler, HP Kim, BK Lee, YY
Citation: Jg. Seol et al., Effect of a novel vitamin D-3 analog, EB1089, on G(1) cell cycle regulatory proteins in HL-60 cells, INT J ONCOL, 16(2), 2000, pp. 315-320
Discovery of OT4003, a novel, potent and orally active Cys-LT1 receptor antagonist (vol 5, pg 415, 1997)
Authors: Tvaermose-Nielsen, O Rachlin, S Dannacher, H Bjorkling, F Kirstein, D Bramm, E Nielsen, CK Mortensen, JT Binderup, L
Citation: O. Tvaermose-nielsen et al., Discovery of OT4003, a novel, potent and orally active Cys-LT1 receptor antagonist (vol 5, pg 415, 1997), BIO MED CH, 8(4), 2000, pp. 841-841
Cyanoguanidine CHS 828 induces programmed cell death with apoptotic features in human breast cancer cells in vitro
Authors: Hansen, CM Hansen, D Holm, PK Larsson, R Binderup, L
Citation: Cm. Hansen et al., Cyanoguanidine CHS 828 induces programmed cell death with apoptotic features in human breast cancer cells in vitro, ANTICANC R, 20(6B), 2000, pp. 4211-4220
Cell cycle arrest induced by the vitamin D-3 analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27
Authors: Park, WH Seol, JG Kim, ES Jung, CW Lee, CC Binderup, L Koeffler, HP Kim, BK Lee, YY
Citation: Wh. Park et al., Cell cycle arrest induced by the vitamin D-3 analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27, EXP CELL RE, 254(2), 2000, pp. 279-286
Apoptosis is induced by the active metabolite of vitamin D-3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implicationsfor prevention and therapy
Authors: Diaz, GD Paraskeva, C Thomas, MG Binderup, L Hague, A
Citation: Gd. Diaz et al., Apoptosis is induced by the active metabolite of vitamin D-3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implicationsfor prevention and therapy, CANCER RES, 60(8), 2000, pp. 2304-2312
The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells
Authors: El Abdaimi, K Dion, N Papavasiliou, V Cardinal, PE Binderup, L Goltzman, D Ste-Marie, LG Kremer, R
Citation: K. El Abdaimi et al., The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells, CANCER RES, 60(16), 2000, pp. 4412-4418
Induction of apoptosis by vitamin D-3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase
Authors: Park, WH Seol, JG Kim, ES Hyun, JM Jung, CW Lee, CC Binderup, L Koeffler, HP Kim, BK Lee, YY
Citation: Wh. Park et al., Induction of apoptosis by vitamin D-3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase, BR J HAEM, 109(3), 2000, pp. 576-583
Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: Comparison with m-iodobenzylguanidine
Authors: Ekelund, S Liminga, G Bjorkling, F Ottosen, E Schou, C Binderup, L Larsson, R
Citation: S. Ekelund et al., Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: Comparison with m-iodobenzylguanidine, BIOCH PHARM, 60(6), 2000, pp. 839-849
Chemistry and pharmacology of calcipotriol
Authors: Kissmeyer, AM Calverley, MJ Binderup, L
Citation: Am. Kissmeyer et al., Chemistry and pharmacology of calcipotriol, VITAMIN D IN DERMATOLOGY, 2000, pp. 169-184
Inhibition of prostate cancer metastasis in vivo: A comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089
Authors: Lokeshwar, BL Schwartz, GG Selzer, MG Burnstein, KL Zhuang, SH Block, NL Binderup, L
Citation: Bl. Lokeshwar et al., Inhibition of prostate cancer metastasis in vivo: A comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089, CANC EPID B, 8(3), 1999, pp. 241-248
Enhanced biological activity of 1 alpha,25-dihydroxy-20-epi-vitamin D-3, the C-20 epimer of 1 alpha,25-dihydroxyvitamin D-3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity
Authors: Siu-Caldera, ML Sekimoto, H Peleg, S Nguyen, C Kissmeyer, AM Binderup, L Weiskopf, A Vouros, P Uskokovic, MR Reddy, GS
Citation: Ml. Siu-caldera et al., Enhanced biological activity of 1 alpha,25-dihydroxy-20-epi-vitamin D-3, the C-20 epimer of 1 alpha,25-dihydroxyvitamin D-3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity, J STEROID B, 71(3-4), 1999, pp. 111-121
The rat subcutaneous air sac model: A quantitative assay of antiangiogenesis in induced vessels
Authors: Lichtenberg, J Hjarnaa, PJV Kristjansen, PEG Hansen, D Binderup, L
Citation: J. Lichtenberg et al., The rat subcutaneous air sac model: A quantitative assay of antiangiogenesis in induced vessels, PHARM TOX, 84(1), 1999, pp. 34-40
Novel 20-epi-vitamin D-3 analog combined with 9-cis-retinoic acid markedlyinhibits colony growth of prostate cancer cells
Authors: Elstner, E Campbell, MJ Munker, R Shintaku, P Binderup, L Heber, D Said, J Koeffler, HP
Citation: E. Elstner et al., Novel 20-epi-vitamin D-3 analog combined with 9-cis-retinoic acid markedlyinhibits colony growth of prostate cancer cells, PROSTATE, 40(3), 1999, pp. 141-149
Risultati: 1-25 | 26-28